LENSAR to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference
LENSAR (Nasdaq: LNSR), a global leader in femtosecond laser solutions for cataract treatment, announced that CEO Nick Curtis will participate in a Fireside Chat at the 2024 Leerink Partners Healthcare Crossroads Conference. This event will take place on May 29, 2024, at 1:40 p.m. CT in Austin, TX.
The live and archived webcast will be accessible via the Investors section of LENSAR's website and will be available for one month after the presentation.
- CEO Nick Curtis will represent LENSAR at a high-profile healthcare conference.
- Participation in the Leerink Partners Healthcare Crossroads Conference may boost investor confidence.
- Availability of a webcast increases transparency and accessibility for investors.
- No specific financial or clinical updates were provided.
- The impact of the conference participation on stock performance remains uncertain.
The live and archived webcast can be accessed through the Investors section of the Company's website at https://ir.lensar.com. The webcast will be available for one month after the presentation has been posted.
About LENSAR
LENSAR is a commercial-stage medical device company focused on designing, developing, and marketing advanced systems for the treatment of cataracts and the management of astigmatism as an integral aspect of the cataract procedure. LENSAR has developed its next-generation ALLY® Adaptive Cataract Treatment System, the first platform to integrate proprietary imaging and software, with an extremely fast dual-pulse femtosecond laser in a compact, highly ergonomic system. ALLY is designed to transform premium cataract surgery by utilizing LENSAR’s advanced technologies with the ability to perform the entire procedure in an operating room or in-office surgical suite, delivering operational efficiencies and reduced overhead. ALLY includes LENSAR’s proprietary Streamline® software technology, designed to guide surgeons to achieve better outcomes.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240522972770/en/
Thomas R. Staab, II, CFO
ir.contact@lensar.com
Lee Roth / Cameron Radinovic
Burns McClellan for LENSAR
lroth@burnsmc.com / cradinovic@burnsmc.com
Source: LENSAR, Inc.
FAQ
What is the stock symbol for LENSAR?
When will LENSAR participate in the 2024 Leerink Partners Healthcare Crossroads Conference?
Who will represent LENSAR at the 2024 Leerink Partners Healthcare Crossroads Conference?
How can I access the webcast of LENSAR's presentation at the conference?
How long will the webcast of LENSAR's Fireside Chat be available?
